期刊文献+

妊娠高血压综合征患者血管内皮细胞损伤指标测定的意义 被引量:8

Dection and Clinical Significance of Vascular Endothelial Cell Damages in Patients with Pregnancy Induced Hypertension Syndrome
下载PDF
导出
摘要 目的探讨妊娠高血压综合征(妊高征)患者血管内皮细胞的改变及其在妊高征血栓前状态(PTS)中的诊断意义。方法应用 ELISA 法及发色底物法测定妊高征患者血中血管性血友病因子(vWF)、组织型纤溶酶原激活物 (tPA)及纤溶酶原激活物抑制剂-1(PAI-1)活性。结果妊高征患者 vWF、tPA、PAI-1 较正常非孕组明显升高,差异有统计学意义(P<0.05或 P<0.01);与正常晚孕组比较,妊高征及各组患者 vWF、PAI-1 活性显著增高(P<0.05或 P< 0.01),且病情越重增高越明显;而 tPA 则无明显改变。中、重度妊高征组血浆 vWF 与 PAI-1水平呈直线正相关关系(r =0.723,P<0.5;r=0.765,P<0.05)。结论妊高征患者由于内皮细胞功能异常,导致了凝血功能及纤溶抑制功能亢进,因此测定血浆中 vWF 和 PAI-1水平,及时发现血管内皮细胞损伤,对于指导临床诊断及治疗具有重要意义。 Objective To explore the changes and clinical significance of plasma yon Willebrand factor (vWF) ,tissue-type plasminogen activator(tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in patients with induced pregnancy hypertension. Methods Plasma vWF, tPA and PAI-1 were determined by ELISA and chromogenic assay respectively in 50 non-pregnancy (control group) ,50 normal pregnancy women (normal pregnancy group) and 85 patients with preganacy induced hypertension (PIH group). Results In normal late pregnancy group and PIH group vWF,tPA and PAI-1 were significently higher than those of con- trol group;In PIH group vWF and PAI-1 were significently higher than those of normal pregnancy group but tPA did not. There was a positive correlation between the plasma vWF and PAI-1 levels in moderate and severe PIH group ( r = 0. 723, P 〈 0.05 ; r = 0. 765, P 〈 0.05 respectively). Conclusion There was endothelial damages in patients with induced pregnancy hypertension. The levels of plasma vWF and PAI-1 may be two indices for the surveillance of PIH. It is important for the diagnosis and therapy of PIH to oberserve the changes of their levels.
出处 《血栓与止血学》 2005年第6期263-265,共3页 Chinese Journal of Thrombosis and Hemostasis
关键词 妊娠高血压综合征 内皮细胞损伤 血管性血友病因子 纤溶酶原激活抑制剂.1 Preganacy induced hypertension Endothelial cell damages von Willebrand factor(vWF) Plasminogen activator inhibitor-1 ( PAI-1 )
  • 相关文献

二级参考文献11

  • 1A. A. Saleh,S. F. Bottoms,A. Monem Farag,M. P. Dombrowski,R. A. Welch,G. Norman,E. F. Mammen.Markers for endothelial injury, clotting and platelet activation in preeclampsia[J].Archives of Gynecology and Obstetrics.1992(3)
  • 2Esmon NL,Owen WG,Esmon CT.Isolation of a membrane- bound cofactor for thrombin- catalyzed activation of protein C[].Journal of Biological Chemistry.1982
  • 3de Groot CJ,Taylor RN.New insights into the etiology of pre- eclampsia[].Annals of Medicine.1993
  • 4Ferris TF.Pregnancy, preeclampsia, and the endothelial cell[].The New England Journal of Medicine.1991
  • 5Simpson AJ,Booth NA,Moore NR,et al.The platelet and plasma pools of plasminogen activator inhibitor (PAI- I) vary independently in disease[].British Journal of Haematology.1990
  • 6Shaarawy M,Didy HE.Thrombomodulin, plasminogen activator inhibitor type- 1 and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia[].International Journal of Gynecology and Obstetrics.1996
  • 7Esmon CT.The roles of protein C and thrombomodulin in the regulation of blood coagulation[].Journal of Biological Chemistry.1989
  • 8Hsu CD,Iriye B,Johnson TRB,et al.Elevated circulating thrombomodulin in severe preeclampsia[].American Journal of Obstetrics and Gynecology.1993
  • 9Robert JM,Taylor RN,Musci TJ,et al.Preeclampsia:an endothelial cell disorder[].American Journal of Obstetrics and Gynecology.1989
  • 10Robert JM,Renman CWG.Preeclampsia: more than pregnancy induced hypertension[].The Lancet.1993

共引文献5

同被引文献40

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部